Daily use of small amounts of aspirin helps prevent covid-19, research

Low-Dose Aspirin May Help Shield You From COVID-19

It is believed that the use of a single pill of aspirin daily can prevent various diseases, only medical experts can tell how true this is.

But preliminary research suggests that daily use of small amounts of aspirin may also, reduce the risk of contracting coronavirus disease Covid-19.

Research has shown that aspirin is an anti-inflammatory drug and previous research reports have suggested that it could potentially help the immune system fight off some viral infections.

The study looked at whether small doses of aspirin could prevent covid- 19 while reducing the duration of the disease.

The study used 75 mg of aspirin daily.

The researchers tracked the data of more than 10,000 people who were diagnosed with covid during the first outbreak of the coronavirus.

Researchers have found that people who use small amounts of aspirin to reduce their risk of heart disease are 29% less likely to be diagnosed with Covid-19 than others.

Similarly, the duration of Covid-19 in aspirin users is 2 to 3 days shorter than in others, depending on whether or not they already have the disease.

The researchers said that the prospect of a low-dose aspirin benefit from Covid-19 was preliminary but encouraging.

He said more research is needed to confirm that aspirin can be beneficial.

"The purpose of this study was to understand the effects of aspirin on the immune system fighting Covid-19, we now intend to work on more people and control clinical trials," he added.

The findings were published in the medical journal The FEBS Journal. 

Aspirin use reduces the risk of death in hospitalized COVID-19 patients. 

image by Flickr

Earlier, in October 2020, a study by the University of Maryland School of Medicine in the United States stated that patients undergoing hospitalization due to Covid-19 should use small amounts of aspirin daily. They may have a reduced risk of complications and death from the disease.

The study claimed that Covid-19 patients using aspirin were less likely to reach the ICU or go to the ventilator support than others. They also have a lower risk of death than those who stay away from the drug.

Expressing "cautious hope" in a study published in the medical journal Anesthesia and Analysis, he said that a cheap and readily available drug could prevent serious complications of Covid-19.

He said it was the most important discovery that needed to be confirmed by a clinical trial if confirmed. This will make aspirin the first widely available drug to reduce the mortality rate of Covid-19 patients.